467 related articles for article (PubMed ID: 37985854)
1. SARS-CoV-2 and innate immunity: the good, the bad, and the "goldilocks".
Sievers BL; Cheng MTK; Csiba K; Meng B; Gupta RK
Cell Mol Immunol; 2024 Feb; 21(2):171-183. PubMed ID: 37985854
[TBL] [Abstract][Full Text] [Related]
2. Innate and adaptive immune responses to SARS-CoV-2 in humans: relevance to acquired immunity and vaccine responses.
Jordan SC
Clin Exp Immunol; 2021 Jun; 204(3):310-320. PubMed ID: 33534923
[TBL] [Abstract][Full Text] [Related]
3. Innate Immune Response and Inflammasome Activation During SARS-CoV-2 Infection.
Islamuddin M; Mustfa SA; Ullah SNMN; Omer U; Kato K; Parveen S
Inflammation; 2022 Oct; 45(5):1849-1863. PubMed ID: 35953688
[TBL] [Abstract][Full Text] [Related]
4. The effects of SARS-CoV-2 infection on modulating innate immunity and strategies of combating inflammatory response for COVID-19 therapy.
Wang Y; Wu M; Li Y; Yuen HH; He ML
J Biomed Sci; 2022 May; 29(1):27. PubMed ID: 35505345
[TBL] [Abstract][Full Text] [Related]
5. The battle between host and SARS-CoV-2: Innate immunity and viral evasion strategies.
Zhang S; Wang L; Cheng G
Mol Ther; 2022 May; 30(5):1869-1884. PubMed ID: 35176485
[TBL] [Abstract][Full Text] [Related]
6. Dysregulated Immune Responses in SARS-CoV-2-Infected Patients: A Comprehensive Overview.
Kudryavtsev I; Rubinstein A; Golovkin A; Kalinina O; Vasilyev K; Rudenko L; Isakova-Sivak I
Viruses; 2022 May; 14(5):. PubMed ID: 35632823
[TBL] [Abstract][Full Text] [Related]
7. The molecular mechanism of SARS-CoV-2 evading host antiviral innate immunity.
Gu W; Gan H; Ma Y; Xu L; Cheng ZJ; Li B; Zhang X; Jiang W; Sun J; Sun B; Hao C
Virol J; 2022 Mar; 19(1):49. PubMed ID: 35305698
[TBL] [Abstract][Full Text] [Related]
8. The immune response to SARS-CoV-2 and COVID-19 immunopathology - Current perspectives.
Boechat JL; Chora I; Morais A; Delgado L
Pulmonology; 2021; 27(5):423-437. PubMed ID: 33867315
[TBL] [Abstract][Full Text] [Related]
9. Host cell-intrinsic innate immune recognition of SARS-CoV-2.
Madden EA; Diamond MS
Curr Opin Virol; 2022 Feb; 52():30-38. PubMed ID: 34814102
[TBL] [Abstract][Full Text] [Related]
10. Innate and Adaptive Immune Responses in the Upper Respiratory Tract and the Infectivity of SARS-CoV-2.
Ramasamy R
Viruses; 2022 Apr; 14(5):. PubMed ID: 35632675
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 Variant Delta Potently Suppresses Innate Immune Response and Evades Interferon-Activated Antiviral Responses in Human Colon Epithelial Cells.
Tandel D; Sah V; Singh NK; Potharaju PS; Gupta D; Shrivastava S; Sowpati DT; Harshan KH
Microbiol Spectr; 2022 Oct; 10(5):e0160422. PubMed ID: 36073824
[TBL] [Abstract][Full Text] [Related]
12. Immunity in SARS-CoV-2 Infection: Clarity or Mystery? A Broader Perspective in the Third Year of a Worldwide Pandemic.
Kapten K; Orczyk K; Smolewska E
Arch Immunol Ther Exp (Warsz); 2023 Feb; 71(1):7. PubMed ID: 36810662
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic understanding of innate and adaptive immune responses in SARS-CoV-2 infection.
Balkhi MY
Mol Immunol; 2021 Jul; 135():268-275. PubMed ID: 33940513
[TBL] [Abstract][Full Text] [Related]
14. Human Nasal and Lung Tissues Infected
Alfi O; Yakirevitch A; Wald O; Wandel O; Izhar U; Oiknine-Djian E; Nevo Y; Elgavish S; Dagan E; Madgar O; Feinmesser G; Pikarsky E; Bronstein M; Vorontsov O; Jonas W; Ives J; Walter J; Zakay-Rones Z; Oberbaum M; Panet A; Wolf DG
J Virol; 2021 Jun; 95(14):e0013021. PubMed ID: 33893170
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19.
Gusev E; Sarapultsev A; Solomatina L; Chereshnev V
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163638
[TBL] [Abstract][Full Text] [Related]
16. Antagonism of Type I Interferon by Severe Acute Respiratory Syndrome Coronavirus 2.
Xia H; Shi PY
J Interferon Cytokine Res; 2020 Dec; 40(12):543-548. PubMed ID: 33337934
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2-mediated evasion strategies for antiviral interferon pathways.
Oh SJ; Shin OS
J Microbiol; 2022 Mar; 60(3):290-299. PubMed ID: 35122601
[TBL] [Abstract][Full Text] [Related]
18. Escape and Over-Activation of Innate Immune Responses by SARS-CoV-2: Two Faces of a Coin.
Mattoo SU; Kim SJ; Ahn DG; Myoung J
Viruses; 2022 Mar; 14(3):. PubMed ID: 35336937
[TBL] [Abstract][Full Text] [Related]
19. Coronaviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines.
Lee S; Channappanavar R; Kanneganti TD
Trends Immunol; 2020 Dec; 41(12):1083-1099. PubMed ID: 33153908
[TBL] [Abstract][Full Text] [Related]
20. Innate immunity during SARS-CoV-2: evasion strategies and activation trigger hypoxia and vascular damage.
Amor S; Fernández Blanco L; Baker D
Clin Exp Immunol; 2020 Nov; 202(2):193-209. PubMed ID: 32978971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
